Search - tctmd.com

Displaying 61 - 80 of 111

Sort: Relevancy | Date

News Daily News

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Shelley Wood

May 06, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

Sweeter Steps: Cocoa May Boost Walking Ability in PAD

L.A. McKeown

February 14, 2020

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

L.A. McKeown

September 16, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Todd Neale

July 24, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Caitlin E. Cox

June 12, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Daily News

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

L.A. McKeown

January 03, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

News Daily News

Varicose Veins Linked to Increased Risk of DVT

L.A. McKeown

February 28, 2018

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Daily News

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

L.A. McKeown

November 08, 2017

Advertisement

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Sweeter Steps: Cocoa May Boost Walking Ability in PAD

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Microvascular Disease Quadruples Risk of Leg Amputation

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

TCTMD’s Top 10 Most Popular Stories for October 2018

Varicose Veins Linked to Increased Risk of DVT

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content